Warwick, RI, United States of America

Shashikant Mehta

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Roger Williams Hospital. Active years: 2006-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shashikant Mehta. Retrieved from https://idiyas.com/inventor/shashikant-mehta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shashikant Mehta: Innovator in Cancer Treatment

Introduction

Shashikant Mehta is a notable inventor based in Warwick, RI (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Mehta's work focuses on enhancing the effectiveness of chemotherapeutic agents in inducing cell death in tumor cells.

Latest Patents

Mehta's latest patents include groundbreaking methods for treating cancer. One of his inventions, titled "Combinations of ceramide and chemotherapeutic agents for inducing cell death and uses thereof in treating cancer," provides a method for increasing apoptosis in tumor cells. This invention outlines a process that involves contacting tumor cells with an effective amount of at least one antitumor chemotherapeutic agent and a ceramide, either sequentially or concomitantly. The combination of these agents results in greater apoptosis than when either agent is used alone. Additionally, this invention offers a pharmaceutical composition that includes both an antitumor chemotherapeutic agent and a ceramide, aimed at effectively inducing apoptosis in tumor cells.

Another patent by Mehta, "Combinations of ceramide and chemotherapeutic agents for inducing tumor cell death," reiterates similar methods for enhancing apoptosis in tumor cells. This invention also emphasizes the importance of administering both an antitumor chemotherapeutic agent and a ceramide to achieve optimal results in cancer treatment.

Career Highlights

Shashikant Mehta is currently affiliated with Roger Williams Hospital, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.

Collaborations

Mehta collaborates with Harold J Wanebo, a fellow professional in the field, to further enhance the impact of their research on cancer treatment.

Conclusion

Shashikant Mehta's innovative contributions to cancer treatment through his patented inventions highlight his commitment to improving patient outcomes. His work in combining ceramide with chemotherapeutic agents represents a significant advancement in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…